Article
The Kidney Cancer Association Seeks Applicants for $1.3 Million in Grant Funding
Young Investigator and Advanced Discovery Awards will advance kidney cancer research, as the Kidney Cancer Association opens up its grant applications.
HOUSTON — March 18, 2020 — The Kidney Cancer Association (KCA) is pleased to announce applications for both its Young Investigator Awards (YIAs) and Advanced Discovery Awards (ADAs) are now open.
A total of $1.3 million in funding will be available:
- Four $75,000 YIAs
- Two $500,000 ADAs
Award recipients will be announced in fall 2020.
“The KCA’s vision is to be the universal leader in finding the cure for kidney cancer,” said Gretchen E. Vaughan, President and CEO of the KCA. “Supporting both seasoned researchers and rising stars in the field through grants is a critical component of how we do that. We’re hoping for a range of exciting projects that will truly move the needle in kidney cancer science and patient care and treatment.”
YIAs encourage promising researchers in urology and clinical oncology who are planning to pursue an investigative career in kidney cancer. ADAs — a new award established in 2019 – promote collaboration between established clinicians and translational researchers to propose new, impactful research. View the 2019 grant recipients here.
YIA applicants are invited to submit full proposals until August 5th. ADA applicants are invited to submit Letters of Intent until May 20th; those accepted for full proposals will be notified by June 10th. An independent panel of expert reviewers will conduct a blinded, scored review of all applications.
Full details on the grants and application guidelines are available on the KCA’s website at www.kidneycancer.org.
###
About The Kidney Cancer Association The Kidney Cancer Association is a global community dedicated to serving and empowering patients and caregivers, and leading change through advocacy, research, and education in order to be the universal leader in finding the cure for kidney cancer. Founded in 1990 by a small group of patients and doctors in Chicago, Illinois, the KCA has grown into an international non-profit organization based in Houston, Texas. The KCA promotes scientific advances through two annual research symposiums and a robust grant program, participates in legislative advocacy, and seeks to be a source of education and resources for patients, caregivers, and anyone impacted by kidney cancer.
